{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:45:47Z","timestamp":1793151947588,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    The proper categorization of mature T-cell neoplasms with coexpression of CD30\/CD15 is unresolved. Prior studies suggested an overlap with ALK-negative anaplastic large cell lymphoma (ALCL). We evaluated the morphologic, immunophenotypic, and molecular features of 28 T-cell lymphomas coexpressing CD30\/CD15, and performed a comparison with 8 ALK\/CD15-negative ALCL and published data. Clinical information was retrieved from the submitting physician. Immunohistochemistry, TRG and IG gene rearrangement, DNA and RNA targeted next-generation sequencing, and fluorescence\n                    <jats:italic toggle=\"yes\">in situ<\/jats:italic>\n                    hybridization for\n                    <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>\n                    rearrangement were performed. Cases were classified as conforming to 3 histologic variants: ALCL-like, Hodgkin-like, and PTCL-NOS-like. Median age was 62 years (range: 33 to 87). Male:female ratio was 3:1. Twenty-four cases presented with lymphadenopathy (24\/28, 85.7%). Six cases had skin involvement (6\/28, 21.4%), including 4 primary cutaneous cases (4\/28, 14.3%). Ten cases were designated as ALCL-like, 12 as Hodgkin-like, and 2 as PTCL-NOS-like. There was frequent loss of T-cell markers, with expression of CD3 in 7\/27 cases (25.9%), CD2 in 15\/23 (65.2%), and expression of at least one cytotoxic marker in 13\/24 (54.2%).\n                    <jats:italic toggle=\"yes\">DUSP22<\/jats:italic>\n                    was rearranged in 4 cases (4\/16, 25%). The JAK-STAT pathway was frequently altered due to mutations in\n                    <jats:italic toggle=\"yes\">JAK1<\/jats:italic>\n                    (6\/28, 21.4%),\n                    <jats:italic toggle=\"yes\">STAT3<\/jats:italic>\n                    (5\/28, 17.8%), and\n                    <jats:italic toggle=\"yes\">JAK2<\/jats:italic>\n                    fusions (2\/28, 7.1%). PI3K-AKT-mTOR pathway alterations due to\n                    <jats:italic toggle=\"yes\">PIK3R1<\/jats:italic>\n                    mutations (5\/28, 17.8%) were also frequent and mutually exclusive with JAK-STAT pathway activation. In summary, most T-cell neoplasms with CD30\/CD15 coexpression share clinical, morphologic, immunophenotypic, and molecular features with\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    -negative ALCL but do not segregate as a homogeneous entity as defined by histologic or genetic features.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002447","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T02:00:08Z","timestamp":1751508008000},"page":"1114-1124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Genomics of T-Cell Lymphomas With CD30\/CD15 Co-Expression"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-3672","authenticated-orcid":false,"given":"Joao V. Alves","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Zgonc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana D.","family":"Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Davies-Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-0301","authenticated-orcid":false,"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R5-20251022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R8-20251022","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","article-title":"JAK2 rearrangements are a recurrent alteration in CD30+ systemic T-Cell lymphomas with anaplastic morphology","volume":"45","author":"Fitzpatrick","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R9-20251022","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/bjh.19442","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative","volume":"204","author":"Ganapathi","year":"2024","journal-title":"Br J Haematol"},{"key":"R10-20251022","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic Features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R11-20251022","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","article-title":"STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma","volume":"35","author":"Lobello","year":"2021","journal-title":"Leukemia"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","article-title":"Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall","volume":"44","author":"Egan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R13-20251022","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R14-20251022","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PAS.0000000000001984","article-title":"Overlapping features of primary cutaneous marginal zone lymphoproliferative disorder and primary cutaneous CD4+ small\/medium t-cell lymphoproliferative disorder: a diagnostic challenge examined by genomic analysis","volume":"47","author":"Obiorah","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R15-20251022","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.gim.2022.07.001","article-title":"Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)","volume":"24","author":"Horak","year":"2022","journal-title":"Genet Med"},{"key":"R16-20251022","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1101\/gr.257246.119","article-title":"Accurate and efficient detection of gene fusions from RNA sequencing data","volume":"31","author":"Uhrig","year":"2021","journal-title":"Genome Res"},{"key":"R17-20251022","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00428-022-03427-z","article-title":"Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities","volume":"482","author":"Tousseyn","year":"2023","journal-title":"Virchows Arch"},{"key":"R18-20251022","first-page":"319","article-title":"CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis","volume":"22","author":"Gorczyca","year":"2003","journal-title":"Int J Oncol"},{"key":"R19-20251022","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"R20-20251022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin\u2019s lymphoma: report of 10 cases","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R21-20251022","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1309\/R2Q9CCUVTLRYCF3H","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R22-20251022","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"R23-20251022","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"key":"R24-20251022","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"R25-20251022","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma","volume":"108","author":"Qiu","year":"2023","journal-title":"Haematologica"},{"key":"R26-20251022","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nature Medicine"},{"key":"R27-20251022","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3324\/haematol.2023.282716","article-title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","volume":"108","author":"Bisig","year":"2023","journal-title":"Haematologica"},{"key":"R28-20251022","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1038\/s41598-022-09889-0","article-title":"Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors","volume":"12","author":"Liu","year":"2022","journal-title":"Sci Rep"},{"key":"R29-20251022","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3324\/haematol.2020.263251","article-title":"Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma","volume":"107","author":"Bastidas Torres","year":"2022","journal-title":"Haematologica"},{"key":"R30-20251022","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1182\/blood-2024-203577","article-title":"Duvelisib in patients with relapsed\/refractory peripheral t-cell lymphoma: final results from the phase 2 PRIMO trial","volume":"144","author":"Mehta-Shah","year":"2024","journal-title":"Blood"},{"key":"R31-20251022","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R32-20251022","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1200\/PO.20.00366","article-title":"Two cases of mycosis fungoides with PCM1-JAK2 fusion","volume":"5","author":"Fernandez-Pol","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"R33-20251022","first-page":"1","article-title":"Hodgkin lymphoma and cutaneous T-cell lymphoma sharing the PCM1-JAK2 fusion and a common T-Cell clone","volume":"3","author":"Riedlinger","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"R34-20251022","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00428-022-03372-x","article-title":"PCM1::JAK2 fusion associates with an atypical form of mycosis fungoides","volume":"481","author":"Rodriguez-Sevilla","year":"2022","journal-title":"Virchows Arch"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:00:23Z","timestamp":1761138023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002447"}},"subtitle":["Comparison With Anaplastic Large-Cell Lymphoma, ALK-Negative"],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002447","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}